GLYDO
FARCO-Pharma Gesellschaft mit beschränkter Haftung Pharmazeutische Präparate
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85023900 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | David C. Purdue |
| Attorney Name | David C. Purdue |
| Attorney Docket Number | 532.1201 |
| Law Office Assigned | M20 |
| Employee Name | BELENKER, ESTHER ANN |
Timeline
| 2010-04-27 | Application Filed |
| 2010-10-12 | Published for Opposition |
| 2010-12-07 | Location: INTENT TO USE SECTION |
| 2012-01-09 | Abandon |
| 2012-01-09 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  FARCO-Pharma Gesellschaft mit beschränkter Haftung Pharmazeutische Präparate |
| Entity Statement | private limited company |
| Address | Gereonsmühlengasse 1-11 Cologne DE 50670 |
| Legal Entity Type | |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Medical lubricant for urological purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2010-04-30 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2010-05-03 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2010-08-06 | 3 DOCK D:Assigned to Examiner |
| PRIORITY ACTION WRITTEN | 2010-08-13 | 4 CPRA R:Renewal |
| PRIORITY ACTION E-MAILED | 2010-08-13 | 5 GPRA F:First Action |
| NOTIFICATION OF PRIORITY ACTION E-MAILED | 2010-08-13 | 6 GPRN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2010-08-19 | 7 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2010-08-19 | 8 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2010-08-19 | 9 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2010-08-19 | 10 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2010-08-27 | 11 CNSA P: |
| ASSIGNED TO LIE | 2010-09-09 | 12 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2010-09-09 | 13 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2010-10-12 | 14 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2010-10-12 | 15 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2010-12-07 | 16 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2011-06-01 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2011-06-01 | 18 EXT1 S: |
| EXTENSION 1 GRANTED | 2011-06-01 | 19 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2011-06-03 | 20 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2012-01-09 | 21 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2012-01-09 | 22 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 GLYDO 86171815 4693348 Live/Registered |
FARCO-PHARMA GMBH 2014-01-22 |
 GLYDO 85023900 not registered Dead/Abandoned |
FARCO-Pharma Gesellschaft mit beschränkter Haftung Pharmazeutische Präparate 2010-04-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 